Natco Pharma Limited has informed the Exchange regarding a press release dated September 18, 2025, titled "NATCO's Pharma division located in Kothur, Hyderabad, India has now received Establishment Inspection Report (EIR) classifying the facility as "Voluntary Action Indicated (VAI)" from the U.S. Food and Drug Administration (FDA)